Diabetes Mellitus Clinical Trials

53 studies are recruiting for diabetes mellitus in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

  1. Early Tracking of Childhood Health Determinants (ETCHED) Study

    Background: Children s weight has increased sharply in recent years. This may put them at higher risk for health problems. High blood glucose in a pregnant mother and too much weight gain during pregnancy also may have long-term effects on the child s health. Children who become overweight or obese…

    Stage
    Not phased
    Ages
    0 to 99
    Site
    NIDDK, Phoenix, Phoenix, Arizona
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  2. Genetic Studies of Insulin and Diabetes

    The study will allow researchers to obtain blood, plasma, DNA, and RNA for genetic studies of insulin. There will be a focus on the causes of insulin resistance and diabetes mellitus. Insulin is a hormone found in the body that controls the level of sugar in the blood. Insulin resistance refers to …

    Stage
    Not phased
    Ages
    0 to 120
    Site
    National Institutes of Health Clinical Center, Bethesda, Maryland
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  3. Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring

    This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Helios Clinical Research, Paradise Valley, Arizona
    Locations
    8 in total
    Run by
    Abbott Diabetes Care
  4. Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

    The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Nationwide Children's Hospital, Columbus, Ohio
    Run by
    Nationwide Children's Hospital
  5. Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes

    This pragmatic clinical trial is being conducted to test the effectiveness of AI-BRIDGE (Artificial Intelligence-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education), in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 8 prima…

    Stage
    Not phased
    Ages
    22 and older
    Site
    UW School of Medicine and Public Health, Madison, Wisconsin
    Run by
    University of Wisconsin, Madison
  6. Palatal Wound Healing After Free Gingival Graft Harvest in Diabetic Patients: A Clinical Trial

    The goal of this clinical trial is to evaluate local and systemic factors involved in palatal mucosal healing after Free Gingival Graft harvest in diabetic patients and to compare them with those in non-diabetic patients. Diabetic and non-diabetic volunteers of both sexes aged ≥ 18 years with gingi…

    Stage
    Not phased
    Ages
    18 and older
    Site
    College of Dentistry - University of Kentucky, Lexington, Kentucky
    Run by
    Mauro Santamaria
  7. Impact GLP-1 Agonists Following Bariatric

    Glucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivity and release of insulin from the pancreas, control hunger, induce satiety and plays a role in the metabolic health of a person. GLP-1 receptor agonists (GLP1-RAs) have been show…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Missouri Hospital, Columbia, Missouri
    Run by
    University of Missouri-Columbia
  8. SPYRAL GEMINI Pilot Study

    The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Stanford Hospital and Clinics, Stanford, California
    Locations
    18 in total
    Run by
    Medtronic Vascular
  9. A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

    The investigators will conduct a feasibility and pilot efficacy randomized controlled trial to test the usability and user satisfaction of an evidence-based digital health tool the investigators developed for clinicians to use to Prioritize Personalize Prescribe EXercise (P3-EX) to patients with ca…

    Stage
    Not phased
    Ages
    18 to 64
    Site
    Hartford HealthCare, Hartford, Connecticut
    Locations
    3 in total
    Run by
    University of Connecticut
  10. A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma

    Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory at Memorial Sloan Kettering to be changed (modified) to become MSLN-targeted CAR T cells, the CAR T-cell therapy that part…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  11. American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

    Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. …

    Stage
    Not phased
    Ages
    21 to 80
    Site
    First Nations Community Health Source, Albuquerque, New Mexico
    Locations
    3 in total
    Run by
    University of New Mexico
  12. Total Contact Soft Cast in Diabetic Foot Ulcers

    To determine the effectiveness, compliance, patient tolerance, ease of use and safety of total contact soft cast in diabetic foot ulcers.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Minnesota, Minneapolis, Minnesota
    Run by
    University of Minnesota
  13. AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

    The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and type 2 diabetes. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the trea…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Univ of Alabama Birmingham, Birmingham, Alabama
    Locations
    74 in total
    Run by
    Novo Nordisk A/S
  14. FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

    The goal of this clinical trial is to learn the best combination of family components that yields optimal weight loss among Black adults. The main question it aims to answer is: What combination of four family components in combination with a standard behavioral weight loss program yields optimal w…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Run by
    University of North Carolina, Chapel Hill
  15. Inflammation, Diabetes, Ethnicity and Obesity Cohort

    Obesity affects over one third of US adults (>72 million, with BMI ≥30 kg/m2), and the proportion of US adults with BMI ≥40 kg/m2 has doubled in the last 20 years. Obesity is associated with increased mortality through its linkage to comorbidities including diabetes, hypertension, dyslipidemia, ost…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    University of California San Francisco, San Francisco, California
    Run by
    University of California, San Francisco
  16. Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH

    The goal of the Arizona Community Engagement Alliance (AZ-CEAL) will be to combine social care with healthcare programs. The study will be connecting selected patients from clinics with trained community health workers (CHW) who will assist participants in getting the help that is needed for their …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Banner University Medical Center South, Tucson, Arizona
    Locations
    2 in total
    Run by
    Sairam Parthasarathy
  17. Impact of Removable Cast Walker Design on Usability for Patients With Diabetic Foot Ulcers

    Within their lifetime, over 30% of people living with diabetes will develop a diabetic foot ulcer (DFU), many of which will never heal and may require amputation. Removable cast walkers (RCWs) are commonly prescribed to offload (treat) DFUs. While RCWs are prescribed to be worn during all weight be…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Rosalind Franklin University of Medicine and Science, North Chicago, Illinois
    Run by
    Rosalind Franklin University of Medicine and Science
  18. Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus

    The purpose of this study is to evaluate efficacy of pioglitazone (PIO) versus empagliflozin (EMPA) to improve glycemic control in people with Chronic Pancreatitis (CP) or Recurrent Acute Pancreatitis (RAP) or Acute Pancreatitis (AP) associated with Diabetes Mellitus (DM). To evaluate mixed meal re…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    3 in total
    Run by
    Mayo Clinic
  19. NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

    Black individuals are more likely to have decreased insulin sensitivity which results in a high risk for the development of cardiometabolic disease. The reasons for this are incompletely understood. Natriuretic peptides (NPs) are hormones produced by the heart that play a role in regulating the met…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham
  20. Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women

    The purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.

    Stage
    Phase 2
    Ages
    24 to 65
    Site
    Arizona State University, Phoenix, Arizona
    Run by
    Arizona State University
  21. Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control

    The purpose of this research is to prove that data generated by your real-time personal continuous glucose monitors CGMs brought in the hospital at the time of hospitalization can be monitored and safely used to guide insulin therapy aiming to improve glycemic control and to diminish the hypoglycem…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mayo Clinic in Florida, Jacksonville, Florida
    Run by
    Mayo Clinic
  22. Care Transitions App for Patients With Multiple Chronic Conditions

    The objective of this study is to widely implement and evaluate the Care Transitions App in a randomized controlled trial. The app the investigators designed for patients with multiple chronic conditions has four envisioned modules: 1) falls-reduction content, 2) a digital post-discharge transition…

    Stage
    Not phased
    Ages
    55 and older
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Run by
    Brigham and Women's Hospital
  23. SPARK-CGM Implementation

    Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in prima…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Montefiore Medical Group (MMG), The Bronx, New York
    Run by
    Montefiore Medical Center
  24. Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

    The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) compared to standard of care when ordered by primary care providers. The main question it aims to a…

    Stage
    Not phased
    Ages
    18 to 89
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Locations
    2 in total
    Run by
    University of Colorado, Denver
  25. Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

    The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy w…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mayo Clinic in Florida, Jacksonville, Florida
    Run by
    Mayo Clinic

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.